Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) | Common Stock [Member] Common Class A [Member] | Common Stock [Member] | Subscription Receivable [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balance at Jan. 31, 2022 | $ 1 | $ 135 | | $ 56,503,616 | $ (57,968,822) | $ (1,465,070) |
Balance, shares at Jan. 31, 2022 | 102,000 | 13,458,752 | | | | |
Shares issued for conversion of notes | | $ 1 | | 44,999 | | 45,000 |
Shares issued for conversion of notes, shares | | 144,304 | | | | |
Resolution of derivative liabilities due to debt conversions | | | | 22,712 | | 22,712 |
Net income (loss) | | | | | 811,838 | 811,838 |
Options issued related to settlement agreement | | | | 44,706 | | 44,706 |
Reclass of APIC to derivative liabilities for tainted warrants | | | | (731,226) | | (731,226) |
Balance at Apr. 30, 2022 | $ 1 | $ 136 | | 55,884,807 | (57,156,984) | (1,272,040) |
Balance, shares at Apr. 30, 2022 | 102,000 | 13,603,056 | | | | |
Balance at Jan. 31, 2022 | $ 1 | $ 135 | | 56,503,616 | (57,968,822) | (1,465,070) |
Balance, shares at Jan. 31, 2022 | 102,000 | 13,458,752 | | | | |
Net income (loss) | | | | | | 626,913 |
Balance at Oct. 31, 2022 | $ 1 | $ 173 | (101,100) | 56,798,397 | (57,341,909) | (644,438) |
Balance, shares at Oct. 31, 2022 | 102,000 | 17,371,752 | | | | |
Balance at Apr. 30, 2022 | $ 1 | $ 136 | | 55,884,807 | (57,156,984) | (1,272,040) |
Balance, shares at Apr. 30, 2022 | 102,000 | 13,603,056 | | | | |
Shares issued for conversion of notes | | $ 5 | | 141,015 | | 141,020 |
Shares issued for conversion of notes, shares | | 539,895 | | | | |
Stock based compensation | | $ 5 | | 163,172 | | 163,177 |
Stock based compensation, shares | | 500,000 | | | | |
Resolution of derivative liabilities due to debt conversions | | | | 55,762 | | 55,762 |
Net income (loss) | | | | | (55,040) | (55,040) |
Issuance of common stock and warrants in private placement and warrant exercises | | | | 5,000 | | 5,000 |
Issuance of common stock and warrants in private placement and warrant exercises, shares | | 13,298 | | | | |
Reclass of APIC to derivative liabilities for tainted warrants | | | | (1,855) | | (1,855) |
Issuance of common shares for subscription receivable | | $ 11 | | 187,019 | | 187,030 |
Issuance of common shares for subscription receivable, shares | | 1,109,804 | | | | |
Balance at Jul. 31, 2022 | $ 1 | $ 157 | | 56,434,920 | (57,212,024) | (776,946) |
Balance, shares at Jul. 31, 2022 | 102,000 | 15,766,053 | | | | |
Cashless exercise of options | | $ 7 | (101,100) | 101,093 | | |
Cashless exercise of options, shares | | 674,000 | | | | |
Shares issued for conversion of notes | | $ 9 | | 114,511 | | 114,520 |
Shares issued for conversion of notes, shares | | 904,961 | | | | |
Stock based compensation | | | | 104,226 | | 104,226 |
Resolution of derivative liabilities due to debt conversions | | | | 39,858 | | 39,858 |
Net income (loss) | | | | | (129,885) | (129,885) |
Issuance of common stock and warrants in private placement and warrant exercises | | | | 5,000 | | 5,000 |
Issuance of common stock and warrants in private placement and warrant exercises, shares | | 26,738 | | | | |
Reclass of APIC to derivative liabilities for tainted warrants | | | | (1,211) | | (1,211) |
Balance at Oct. 31, 2022 | $ 1 | $ 173 | (101,100) | 56,798,397 | (57,341,909) | (644,438) |
Balance, shares at Oct. 31, 2022 | 102,000 | 17,371,752 | | | | |
Balance at Jan. 31, 2023 | $ 1 | $ 186 | (117,468) | 56,941,222 | (57,403,227) | (579,286) |
Balance, shares at Jan. 31, 2023 | 102,000 | 18,671,159 | | | | |
Receipt of subscription receivable | | | 16,368 | | | 16,368 |
Cashless exercise of options | | $ 3 | (16,750) | 16,747 | | |
Cashless exercise of options, shares | | 250,000 | | | | |
Shares issued for conversion of notes | | $ 13 | | 70,930 | | 70,943 |
Shares issued for conversion of notes, shares | | 1,251,270 | | | | |
Stock based compensation | | | | 19,265 | | 19,265 |
Stock based compensation, shares | | | | | | |
Resolution of derivative liabilities due to debt conversions | | | | 43,931 | | 43,931 |
Net income (loss) | | | | | (118,579) | (118,579) |
Balance at Apr. 30, 2023 | $ 1 | $ 202 | (117,850) | 57,092,095 | (57,521,806) | (547,358) |
Balance, shares at Apr. 30, 2023 | 102,000 | 20,172,429 | | | | |
Balance at Jan. 31, 2023 | $ 1 | $ 186 | (117,468) | 56,941,222 | (57,403,227) | (579,286) |
Balance, shares at Jan. 31, 2023 | 102,000 | 18,671,159 | | | | |
Shares issued for conversion of notes, shares | | 5,666,917 | | | | |
Net income (loss) | | | | | | (574,567) |
Balance at Oct. 31, 2023 | $ 3 | $ 498 | (117,850) | 58,423,801 | (57,977,794) | 328,658 |
Balance, shares at Oct. 31, 2023 | 250,000 | 49,813,861 | | | | |
Balance at Apr. 30, 2023 | $ 1 | $ 202 | (117,850) | 57,092,095 | (57,521,806) | (547,358) |
Balance, shares at Apr. 30, 2023 | 102,000 | 20,172,429 | | | | |
Shares issued for conversion of notes | | $ 17 | | 61,078 | | 61,095 |
Shares issued for conversion of notes, shares | | 1,690,073 | | | | |
Stock based compensation | | $ 10 | | 24,354 | | 24,364 |
Stock based compensation, shares | | 978,300 | | | | |
Resolution of derivative liabilities due to debt conversions | | | | 125,520 | | 125,520 |
Net income (loss) | | | | | (203,379) | (203,379) |
Issuance of common stock and warrants in private placement and warrant exercises | | $ 35 | | 159,965 | | 160,000 |
Issuance of common stock and warrants in private placement and warrant exercises, shares | | 3,542,778 | | | | |
Balance at Jul. 31, 2023 | $ 1 | $ 264 | (117,850) | 57,463,012 | (57,725,185) | (379,758) |
Balance, shares at Jul. 31, 2023 | 102,000 | 26,383,580 | | | | |
Shares issued for conversion of notes | | $ 27 | | 101,215 | | 101,242 |
Shares issued for conversion of notes, shares | | 2,725,574 | | | | |
Stock based compensation | | | | 19,614 | | 19,614 |
Resolution of derivative liabilities due to debt conversions | | | | (11,241) | | (11,241) |
Net income (loss) | | | | | (252,609) | (252,609) |
Issuance of common stock and warrants in private placement and warrant exercises | $ 4 | $ 205 | | 851,201 | | 851,410 |
Issuance of common stock and warrants in private placement and warrant exercises, shares | 398,000 | 20,454,707 | | | | |
Shares exchanged | $ (2) | $ 2 | | | | |
Shares exchanged, shares | (250,000) | 250,000 | | | | |
Balance at Oct. 31, 2023 | $ 3 | $ 498 | $ (117,850) | $ 58,423,801 | $ (57,977,794) | $ 328,658 |
Balance, shares at Oct. 31, 2023 | 250,000 | 49,813,861 | | | | |